首页> 外文期刊>Clinical nuclear medicine >Schwannoma Showing Avid Uptake on Ga-68-PSMA-HBED-CC PET/CT
【24h】

Schwannoma Showing Avid Uptake on Ga-68-PSMA-HBED-CC PET/CT

机译:Schwannoma对Ga-68-PSMA-HBED-CC PET / CT表现出强烈的摄取

获取原文
获取原文并翻译 | 示例
           

摘要

Ga-68 prostate-specific membrane antigen (PSMA) PET/CT is a relatively new and highly sensitive imaging modality used in staging metastatic prostate cancer. We report a case of a 65-year-old man with newly diagnosed prostate carcinoma who had a PSMA PET/CT scan for staging of his disease. A PSMA-avid right pelvic mass was identified anterior to the sacrum. Surgical removal and histopathological examination of this lesion revealed the diagnosis of schwannoma. It is important to be aware that schwannoma may also show avid uptake on PSMA PET/CT scan and may potentially lead to an incorrect diagnosis of metastatic prostate carcinoma.
机译:Ga-68前列腺特异性膜抗原(PSMA)PET / CT是用于分期转移性前列腺癌的相对较新的高度敏感的影像学检查方法。我们报告了一例65岁的新诊断为前列腺癌的男人,该患者接受了PSMA PET / CT扫描以检查其疾病分期。在the骨之前发现了一个PSMA严重的右骨盆肿块。对该病灶的手术切除和组织病理学检查显示出神经鞘瘤的诊断。重要的是要意识到,神经鞘瘤还可能在PSMA PET / CT扫描中显示出强烈的摄取,并可能潜在地导致对转移性前列腺癌的错误诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号